Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000197657 | SCV000252177 | uncertain significance | not specified | 2014-09-15 | criteria provided, single submitter | clinical testing | c.772-4_772-3delTT: IVS9-4_-3delTT in intron 9 of the RARS2 gene (NM_020320.3). The normal sequence with the bases that are deleted in braces is: tctt{tt}agCG with the exonic bases in upper case and the intronic bases in lower case. A variant of unknown significance has been identified in the RARS2 gene. The c.772-4_-3delTT variant has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. In silico analysis predicts this variant may damage or destroy the natural splice acceptor site in intron 9 leading to abnormal splicing. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic mutation or a rare benign variant. The variant is found in MITONUC-MITOP panel(s). |
Labcorp Genetics |
RCV002517255 | SCV003282059 | likely benign | not provided | 2024-03-05 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001833151 | SCV002079905 | uncertain significance | Pontocerebellar hypoplasia type 6 | 2019-11-11 | no assertion criteria provided | clinical testing |